When the maker of a brand-name drug pays a maker of generic drugs to not produce a lower-priced version of their product, the Federal Trade Commission can challenge the arrangement on antitrust grounds, the Supreme Court ruled Monday. The ruling may end the era of what regulators call "pay-for-delay" deals.
The justices voted 5-3 to allow a case to go forward in which the FTC is challenging one of many such deals. Several companies are involved in the case, including Solvay Pharmaceuticals, maker of AndroGel, and generic-drug maker Actavis.
Iran's newly elected president, Hasan Rowhani, gave a news conference in the capital Tehran on Monday. He said he would pursue a path of moderation.
Credit Ebrahim Noroozi / AP
Hasan Rowhani's victory in Iran's presidential election produced street celebrations in Tehran on Saturday, in sharp contrast to the weeks of violent protests that followed a disputed election four years ago. Rowhani is being hailed as a moderate, though hard-line clerics are still seen as the most powerful force in the country.
Ever since Iran's 1979 Islamic Revolution, the U.S. has been in search of moderate Iranian leaders who could steer the country away from its hostile standoff with America.
To cite one famous example, President Ronald Reagan's administration secretly sold weapons to Iran in the mid-1980s in the belief it could work with the country's "moderate" elements even as Iran remained under the control of revolutionary leader Ayatollah Ruhollah Khomeini.
Dearly beloved, we are gathered here today not to mourn the nine-patty T-Rex Burger, but to celebrate its life. It was pulled this week, far too young, from the menu of a rogue Manitoba Wendy's that served it to two or three people a day. It is survived by the few people who ate it and survived.
Said a Wendy's spokesperson: "For obvious reasons, Wendy's ... neither condones nor promotes the idea of anyone consuming a nine-patty hamburger in one sitting."